Michael Elgort
Parkman Healthcare Partners Llc
Assets Managed
$969.641M
Holdings
90
Last Quarter
2026 - Q1
Filed Date
11d ago
Growth Rate
-7.69%(2Q avg: 0.94%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in Parkman Healthcare Partners Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 90 positions.
Assets under management
The assets under management (AUM) of Parkman Healthcare Partners Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 969.641M in assets, with a quarterly growth rate of -7.69% and a 2-quarter average growth rate of 0.94%. The portfolio is managed by Michael Elgort, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
SYK Stryker Corp
| 5.25% | $50.856M 154,771 shares@ $328.6 avg price | Increased 46.75% |
DXCM Dexcom Inc
| 4.47% | $43.321M 689,822 shares@ $62.81 avg price | Increased 17.43% |
KALV Kalvista Pharmaceuticals Inc
| 3.82% | $36.949M 1.836M shares@ $20.14 avg price | Increased 3.79% |
PODD Insulet Corp
| 3.39% | $32.853M 156,561 shares@ $209.84 avg price | Increased 11.15% |
LLY Eli Lilly & Co
| 3.29% | $31.839M 34,616 shares@ $919.77 avg price | New Position |
PTCT Ptc Therapeutics Inc
| 3.04% | $29.389M 431,364 shares@ $68.13 avg price | Increased 169.31% |
XENE Xenon Pharmaceuticals Inc
| 2.99% | $28.903M 497,035 shares@ $58.15 avg price | Increased 222.37% |
BSX Boston Scientific Corp
| 2.91% | $28.16M 448,768 shares@ $62.75 avg price | Decreased -10.34% |
CVS Cvs Health Corp
| 2.87% | $27.816M 387,306 shares@ $71.83 avg price | Decreased -13.97% |
RCUS Arcus Biosciences Inc
| 2.69% | $26.077M 1.207M shares@ $21.6 avg price | Increased 24.65% |
1-10 of 90